Pharmaceutiques company information, Employees & Contact Information

Trump's pharma tariffs on hold amid administration's effort to secure pricing concessions, industry investment: Stat Fierce Pharma

Julie Wierzbicki: ASCO 2025 Highlights - Liquid Biopsy and Advances in Small Cell Lung Cancer Oncodaily

SCHOTT Pharma Launches Next Gen Polymer Syringe System Contract Pharma

Pint Pharma Announces ANVISA’s Approval of BESREMi® (ropeginterferon alfa-2b) for the Treatment of Polycythemia Vera Business Wire

Merck will lay off 6,000, reducing workforce by 8% in cost-cutting purge Fierce Pharma

OnCusp’s CUSP06 Receives FDA Fast Track Designation Contract Pharma

Mapi Pharma is Seeking New Depot Product Partnerships GlobeNewswire

EyePoint Investor Relations EyePoint Pharmaceuticals

After recall, Pfizer warns of 'near-term stock out' of penicillin product used to treat syphilis in pregnant women Fierce Pharma

Top 20 Pharma and BioPharma Companies Archives Contract Pharma

2024 drug approvals: Small companies loom large with several key FDA nods Fierce Pharma

Vetter Pharma International Contract Pharma

JPM25: After taking the wheel at Acadia, CEO Catherine Owen Adams looks to steer firm toward $1B in sales Fierce Pharma

Adragos Pharma Acquires Swiss Sterile Fill-Finish Firm Baccinex Contract Pharma

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on Fierce Pharma

Sumitomo Pharma, suffering from sliding sales, lays off another 400 US staffers Fierce Pharma

Two-thirds of top 20 pharmas have banned ChatGPT—and many in life sci call AI 'overrated,' survey finds Fierce Pharma

Pharmas are underutilizing social media to communicate with doctors and patients, HCPs say Fierce Pharma

As Vyvanse generics bite, Takeda sets out on $900M restructuring plan Fierce Pharma

Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus Fierce Pharma

Bankrupt Akorn Pharma calls it quits and closes all US sites, laying off entire workforce Fierce Pharma

ONO begins Airing New Commercial “Rising to the challenges of Immuno-Oncology” in Japan ono-pharma.com

Global Biotechnology Company Global Biotechnology Company

Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchase Fierce Pharma

Leadership Spotlight: Thomas Otto & Peter Soelkner Contract Pharma

LEO Pharma Closes Deal for Spevigo® Yahoo Finance

MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology Yahoo Finance

Medicines From Purdue purduepharma.com

After triumphant pilot, GSK eyes 'digital twins' to fine-tune vaccine production, development Fierce Pharma

CRO Industry Report Contract Pharma

Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection Yahoo Finance

Coriolis Pharma Opens New Laboratory at Spark Life Science Campus in Morrisville, North Carolina Biotech Newswire

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO® (spesolimab) Yahoo Finance

LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris Yahoo Finance

Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies PR Newswire

Recordati to acquire EUSA Pharma for €750m, gaining 4 rare cancer drugs Fierce Pharma

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update Business Wire

Coriolis Pharma Appoints Peter Sölkner to Board of Directors to Support the Company’s Growth Ambitions Biotech Newswire

Pharmaceutical Aptar

Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) Yahoo Finance

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) Yahoo Finance

Horus Pharma Pushes Ahead With Its European Expansion Yahoo Finance

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians Yahoo Finance

SK Capital buys generics producer Apotex, troubled since the murder of founder Barry Sherman Fierce Pharma

Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1) Business Wire

LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis Yahoo Finance

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases Business Wire

Pint Pharma Announces INVIMA’s Approval of ORLADEYO® (berotralstat), the First Oral Therapy for Preventing Hereditary Angioedema (HAE) Attacks in Patients Aged 12 and Older in Colombia Business Wire

MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease Business Wire

Knight Therapeutics and Sumitomo Pharma enter into GlobeNewswire

Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil Business Wire

NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer Business Wire

Yingli Pharma Doses First US Patient in Phase 1 Study of YL-13027 for Patients with Advanced Solid Tumors GlobeNewswire

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project Business Wire

Pint Pharma announces the approval of ORLADEYO® (berotralstat), the first oral therapy indicated to prevent hereditary angioedema (HAE) attacks in adults and children 12 years and older in Peru. Business Wire

Love Pharma Inc., Announces Listing on Frankfurt Stock Exchange Investing News Network

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH GlobeNewswire

F.P.S. Food and Pharma Systems Srl European Pharmaceutical Review

Sunovion Pharmaceuticals Inc. to Divest Xopenex® (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc. Fierce Pharma

LEO Pharma appoints new Chief Financial Officer and Executive Vice President Via Ritzau

LEO Pharma A/S appoints Brian Hilberdink new President of LEO Pharma Inc. United States Via Ritzau

Celtic Pharma targets $1.5bn for drug makers Financial News London

LEO Pharma strengthens global leadership team with appointment of new EVP People & Communications Via Ritzau

Birgitta Stymne Göransson elected member of LEO Pharma’s Board of Directors Via Ritzau

Olivier Bohuon elected to LEO Pharma’s Board of Directors Via Ritzau